Variables

Urban (N = 61) n (%)

Rural (N = 37) n (%)

Total

X2

p Value

Sex

Male

33 (54.1)

15 (40.5)

48 (49.0)

1.694

0.193

Female

28 (45.9)

22 (59.5)

50 (51.0)

Age

<20

13 (21.3)

11 (29.7)

24 (24.5)

3.439

0.633

20 - 29

6 (9.8)

4 (10.8)

10 (10.2)

30 - 39

24 (39.3)

10 (27.0)

34 (34.7)

40 - 49

14 (23.0)

8 (21.6)

22 (22.4)

50 - 59

4 (6.6)

3 (8.1)

7 (7.1)

60 - 69

0 (0.0)

1 (2.7)

1 (1.0)

Weight (kg)

<20

5 (8.2)

7 (18.9)

12 (12.2)

6.507

0.482

20 - 29.9

4 (6.6)

3 (8.1)

7 (7.1)

30 - 39.9

3 (4.9)

1 (2.7)

4 (4.1)

40 - 49.9

14 (23.0)

8 (21.6)

22 (22.4)

50 - 59.9

16 (26.2)

13 (35.1)

29 (29.6)

60 - 69.9

12 (19.7)

4 (10.8)

16 (16.3)

70 - 79.9

6 (9.8)

1 (2.7)

7 (7.1)

Missing

1 (1.6)

0 (0.0)

1 (1.0)

Site of disease

Pulmonary

55 (90.2)

35 (94.6)

90 (91.8)

0.603

0.437

Extrapulmonary

6 (9.8)

2 (5.4)

8 (8.2)

Sputum AFB Status

Positive

21 (35.0)

15 (40.5)

36 (37.1)

2.077

0.557

Negative

27 (45.0)

16 (43.2)

43 (44.3)

Unable to produce sputum

9 (15.0)

6 (16.2)

15 (15.5)

Others

3 (5.0)

0 (0.0)

3 (3.1)

Antiretroviral treatment status

On treatment:

30 (49.2)

16 (43.2)

46 (46.9)

0.326

0.568

Not on treatment

31 (50.8)

21 (56.6)

52 (53.1)

Treatment regimen

Category 1

59 (96.7)

35 (94.6)

94 (95.9)

0.266

0.606

Category 2

2 (3.3)

2 (5.4)

4 (4.1)